OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

PHARMING GRP EO-,01/  NL0010391025  /

Frankfurt
04/09/2024  08:09:58 Chg. - Volume Bid07:28:20 Ask07:28:20 High Low
0.6745EUR - 0
Turnover: 0.0000		 0.6745Bid Size: 1,500 0.6885Ask Size: 1,500 0.6745 0.6745
GlobeNewswire 01/08 Pharming Group reports second quarter and first half 2024 financial results and provides business up...
GlobeNewswire 18/07 Pharming Group to report second quarter and first half 2024 financial results on August 1
GlobeNewswire 03/06 Pharming Group to participate in June investor conferences
GlobeNewswire 21/05 Pharming Group reports on results of the 2024 Annual General Meeting of Shareholders
GlobeNewswire 20/05 Pharming Group to participate in May investor conference
GlobeNewswire 08/05 Pharming Group reports first quarter 2024 financial results and provides business update
GlobeNewswire 24/04 Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 20...
GlobeNewswire 08/04 Pharming announces completion of enrollment in pediatric clinical trial of leniolisib
GlobeNewswire 03/04 Pharming Group to participate in April investor conferences
GlobeNewswire 14/03 Pharming Group reports fourth quarter and full year 2023 financial results
GlobeNewswire 29/02 Pharming Group to report fourth quarter and full year 2023 financial results on March 14
GlobeNewswire 08/02 Pharming Group to participate in February investor conferences
GlobeNewswire 08/01 Pharming Group announces updated full year 2023 guidance and Joenja® U.S. launch update
GlobeNewswire 13/12/2023 Pharming Group announces development plans for leniolisib for additional primary immunodeficiencies ...
GlobeNewswire 21/11/2023 Pharming announces first patient dosed in pediatric clinical trial for children aged 1 to 6 years fo...
GlobeNewswire 01/11/2023 Pharming Group to participate in November investor conferences
GlobeNewswire 26/10/2023 Pharming Group reports third quarter 2023 financial results
GlobeNewswire 12/10/2023 Pharming Group to report third quarter 2023 financial results on October 26
GlobeNewswire 25/09/2023 Pharming Group reports on results of the 2023 Extraordinary General Meeting of Shareholders
GlobeNewswire 06/03/2014 Pharming Reports On Preliminary Financial Results 2013
GlobeNewswire 24/02/2014 PHARMING AND SALIX ANNOUNCE EXTENSION OF PDUFA ACTION DATE FOR RUCONEST®
GlobeNewswire 08/11/2013 PHARMING AND SANTARUS ANNOUNCE NEW DATA FROM OPEN-LABEL REPEAT TREATMENT STUDY WITH RUCONEST
GlobeNewswire 07/11/2013 Pharming Reports On Financial Results For The First Nine Months Of 2013
GlobeNewswire 09/10/2013 Pharming announces €12.0 million private equity placement with institutional investors
GlobeNewswire 29/08/2013 Pharming redeems final tranche of convertible bond for cash